Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Total Liabilities (2016 - 2025)

Historic Total Liabilities for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to $58.8 million.

  • ProPhase Labs' Total Liabilities rose 961.03% to $58.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.8 million, marking a year-over-year increase of 961.03%. This contributed to the annual value of $55.8 million for FY2024, which is 3126.88% up from last year.
  • Latest data reveals that ProPhase Labs reported Total Liabilities of $58.8 million as of Q3 2025, which was up 961.03% from $30.6 million recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Total Liabilities ranged from a high of $58.8 million in Q3 2025 and a low of $24.0 million during Q4 2022
  • Its 5-year average for Total Liabilities is $37.2 million, with a median of $33.2 million in 2022.
  • Its Total Liabilities has fluctuated over the past 5 years, first soared by 254987.87% in 2021, then crashed by 3829.89% in 2025.
  • Quarter analysis of 5 years shows ProPhase Labs' Total Liabilities stood at $30.7 million in 2021, then fell by 21.68% to $24.0 million in 2022, then surged by 77.14% to $42.5 million in 2023, then soared by 31.27% to $55.8 million in 2024, then increased by 5.36% to $58.8 million in 2025.
  • Its last three reported values are $58.8 million in Q3 2025, $30.6 million for Q2 2025, and $35.0 million during Q1 2025.